Erlotinib (Tarceva): a promising drug targeting epidermal growth factor receptor tyrosine kinase.
Expert review of anticancer therapy. 2003.
Navigate to...
Show section selector dropdown
Unsupported tab "automatedAnnotation"
Unsupported tab "automatedAnnotation"